-
Product Insights
Eiffage Amenagement/ Igny/ SEQENS – Joliot-Curie Residential District Redevelopment – Ile-de-France
Equip yourself with the essential tools needed to make informed and profitable decisions with our Eiffage Amenagement/ Igny/ SEQENS - Joliot-Curie Residential District Redevelopment - Ile-de-France report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
ENGIE Group/ SEQENS – Nancy Biomass Cogeneration Power Plant 14.6 MW – Grand-Est
Equip yourself with the essential tools needed to make informed and profitable decisions with our ENGIE Group/ SEQENS - Nancy Biomass Cogeneration Power Plant 14.6 MW - Grand-Est report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full...
-
Sector Analysis
Mergers and Acquisitions (M&A) in the Contract Manufacturing Industry – Implications and Outlook – 2023 Edition
M and A In Pharmaceutical Contract Manufacturing Industry Report Overview During 2018–22, contract manufacturing organization (CMO) merger and acquisition (M&A) deal activity increased, and the targeted manufacturers have adopted specialized capabilities such as controlled substance and containment manufacture. Despite considerable macroeconomic challenges for pharma manufacturers, 2021–22 witnessed strong M&A activity and CMO valuations, although there was a slight decline in CMO M&A activity in 2022 due to rising inflation and interest rates. The Mergers and Acquisitions (M&A) in the Contract...
-
Sector Analysis
China Contract Manufacturing Market Outlook – Trends, Ambitions, Key Players, Investment and Value Chain
There is an increasing reliance on contract manufacturing and development services due to the growing regulatory complexity surrounding drug production and development. China has been focusing on establishing volume and enhancing capabilities for innovative high-value drug production. This will enable the Chinese pharma manufacturers to compete with US and European equivalents in terms of obtaining contracts for lucrative treatments such as gene and cell therapies. China is also upgrading its manufacturing capabilities, boosting innovation, and strengthening its position in a...
-
Product Insights
SEQENS – Roussillon Pharmaceutical Plant Development – Occitania
Equip yourself with the essential tools needed to make informed and profitable decisions with our SEQENS - Roussillon Pharmaceutical Plant Development - Occitania report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...